Skip to content
Saturday, November 14, 2026
DeltaBet Canada

The Zimbabwean Government Turns Down ‘Unbalanced’ US Health Aid Deal Due to Data Fears

Health funding illustration
The proposed US funding was aimed at initiatives for treating and preventing HIV/Aids, TB, and malaria.

Zimbabwe has declined a substantial US healthcare agreement worth $367m (272 million pounds) spanning five years because of Washington's insistence on confidential biological samples.

This rejection came to light following a official document from December was disclosed, revealing that President Emmerson Mnangagwa believed the arrangement was "skewed".

A government spokesperson has since stated that the United States was requesting health data for scientific study and commercial purposes but was unwilling to guarantee the resulting advantages from future treatments.

"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last two decades.

A medical body in Zimbabwe has appealed for more negotiations to find a agreement agreeable to both sides so the nation's critical HIV programme can continue.

Wider Background

This development comes after a similar situation in Kenya, where a court blocked a similar health funding agreement after concerns were raised about the security of Kenyans' health data.

After resuming office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

USAID had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance openness and accountability.

Based on reports, 16 African countries have to date signed similar agreements, constituting over $18.3bn of fresh investment.

Details of the Rejected Agreement

The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy through American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to provide its biological resources and data indefinitely, with no equivalent assurance of access to any scientific breakthroughs – like new medicines or tests – that could result from that provided information," his statement read.

"Put simply, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be available to our people should a new health crisis arise."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending frameworks already established via the international organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing framework created to deal with future global health emergencies.

"This framework is designed to guarantee that when a country provides its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."

The government's concerns over the US deal "should not be misconstrued as opposition to America," Mangwana stressed.

"We welcome continued dialogue with our American counterparts on how future collaboration might be designed in a way that respects the independence and interests of each country."

Health Experts Response

A leading public health body stated it recognised the government's concerns, but recommended that negotiations must proceed considering a large portion of the nation's HIV programmes depended on international support.

"If specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be addressed via detailed discussion and negotiated safeguards," it commented.

This impasse emphasises the ongoing debate between accepting vital international aid and protecting a country's data in an increasingly interconnected world.

About the author

Ryan Torres

A seasoned sports analyst and casino reviewer with over a decade of experience in the Canadian gambling industry.

DeltaBet Canada

Type to search articles.